BASF Sells Oil & Gas Unit, Shifts Strategy with Major Investments
BASF has enacted sweeping strategic changes, simultaneously shedding legacy assets and funneling capital into new growth areas. The German chemicals giant completed the sale of its oil and gas exploration business (Wintershall Dea’s E&P unit) in August, a divestment affecting about 800 employees and yielding over ¥100 billion in cash proceeds . BASF plans to reinvest this windfall into major projects, notably its new €10 billion integrated Verbund site in Zhanjiang, China, and expansions in battery materials and green energy . In tandem, BASF signed a memorandum of understanding with China’s Fourier Intelligent to co-develop new materials for next-generation humanoid robots, signaling a push into high-tech specialty products.
These moves come as BASF aggressively streamlines operations to cut costs amid a tough global market. Over the past year, the company has shut down multiple production units in Europe (including several at its Ludwigshafen flagship site) and even exited a chemical joint venture in Xinjiang, China. BASF’s CEO Martin Brudermüller noted that more plant closures in Germany are possible as part of an ongoing efficiency program. By pruning lower-margin businesses and doubling down on innovation and Asian growth projects, BASF is repositioning itself for long-term profitability despite near-term headwinds of overcapacity and fierce competition in China.
2026-10-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Exit! Why Did Clariant Divest Its Venezuelan Business at a “Low Price”?
-
Can the Manufacturing Sector Withstand Dow’s April Polyethylene Price Doubling?
-
Sinopec and LG Chem Sign Agreement to Jointly Develop Sodium-Ion Battery Materials
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Mitsubishi Chemical to Halt Production of Key Epoxy Resin Grades by 2027
-
Brazil’s SISPA Platform Signals a New Phase in Pesticide Registration
-
$14.5 Billion Solstice–Element Solutions Merger Abruptly Terminated Less Than Two Months After Announcement
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
Recommend Reading
-
Indorama Secures RMB 2.4 Billion Loan to Expand Urea Capacity in Anyang
-
From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”
-
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
Lilly Bets US$3 Billion on China While Simultaneously Cracking Down on the Gray Market for Weight-Loss Drugs
-
Luyin Investment subsidiary Heze Salt introduces Wanhua Chemical as strategic investor with RMB 333 million capital increase
-
Cost Floor, Supply-Demand Shift—Butadiene Rises First, Then Falls
-
Business Society’s Trend Analysis for Propylene Oxide on September 15, 2026: Strong Consolidation (Bullish)
-
Business Society’s Maleic Anhydride Trend Analysis for September 15, 2026: Rising
-
Business Society’s Toluene Trend Analysis for September 16, 2026: Volatile Fluctuations
-
March 12 International Crude Oil Opens with a Sharp Rise in Asian Trading Session